nach oben

Erschienen in:

01.02.2008

Visual impairment and quality of life: gender differences in the elderly in Cuenca, Spain

verfasst von: J. J. Navarro Esteban, M. Solera Martínez, P. García Navalón, O. Piñar Serrano, J. R. Cerrillo Patiño, M. E. Calle Purón, V. Martínez-Vizcaíno

Erschienen in: Quality of Life Research | Ausgabe 1/2008

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Purpose

To estimate the prevalence of visual impairment (VI) in a population sample of older adults of the province of Cuenca, Spain and to evaluate the impact of VI on health-related quality of life (HRQOL) in this population group.

Methods

Cross-sectional observational study of the cohort of all persons over the age of 64 years from an urban area and rural nucleus of the province of Cuenca, Spain. Sociodemographic data were obtained and the VF-14 and SF-12 questionnaires were administered in an interview. One ophthalmologist evaluated the visual acuity (VA) and the presence of lens opacities, glaucoma, diabetic retinopathy, and age-related maculopathy. Prevalence of VI and blindness was defined according to the WHO criteria (0.5 log MAR ≤ VA < 1.2 log MAR and VA ≥ 1.2 log MAR) and the European criteria (0.3 log MAR ≤ VA < 1 log MAR and VA ≥ 1 log MAR) in the better eye.

Results

The study enrolled 1155 people out of a total of 1435 who were invited to participate (response rate 80.5%). The prevalence of VI and blindness according to the WHO criteria was 6.3 and 2%, respectively. Using the European criteria, the prevalence of VI was 21.1 and 2.4% the prevalence of blindness. The prevalence of VI was greater in older subjects (p < 0.0001); no significant gender-related differences were observed. The mean VF-14 score and means of the Physical Composite Score (PCS) and Mental Composite Score (MCS) of the SF-12 were lower in women than in men for all categories of visual acuity. The mean VF-14 score diminished as the degree of VI increased in all the pathologies studied, except glaucoma. The mean PCS score differed significantly by categories of VI, cataract, and diabetic retinopathy. The mean MCS score only differed with the degree of impairment of diabetic retinopathy.

Conclusions

The prevalence of VI was among the highest reported until now in adults over 64 years old and increased with age. The deterioration in quality of life related to visual function increased with increased degree of VI for all the pathologies studied (cataract, diabetic retinopathy, age-related maculopathy) except glaucoma. The HRQOL was consistently worse in women than in men for all categories of deterioration of visual acuity.

Vorheriger Artikel Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors

Nächster Artikel Analyzing growth and change: latent variable growth curve modeling with an application to clinical trials

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 340 Zeitschriften

aus folgenden Fachgebieten:

Bauwesen + Immobilien
Business IT + Informatik
Finance + Banking
Management + Führung
Marketing + Vertrieb
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Tielsch, J. M., Sommer, A., UIT, K., Katz, J., & Royall, R. M. (1990). Blindness and visual impairment in an American urban population: The Baltimore eye survey. Archives of Ophthalmology, 108, 286–290.PubMed

Klein, R., Klein, B. E., Linton, K. L., & De Mets, D. L. (1991). The beaver dam eye study: Visual acuity. Ophthalmology, 98, 1310–1315.PubMed

Attebo, K., Mitchell, P., & Smith, W. (1996). Visual acuity and the causes of visual loss in Australia: The blue mountains eye study. Ophthalmology, 103, 357–364.PubMed

Ivers, R. Q., Cumming, R. G., Mitchell, P., & Attebo, K. (1998). Visual impairment and falls in older adults: The blue mountains eye study. Journal of the American Geriatrics Society, 46, 58–64.PubMed

Ivers, R. Q., Norton, R., Cumming, R. G., Butler, M., & Campbell, A. J. (2000). Visual impairment and risk of hip fracture. American Journal of Epidemiology, 152, 633–639.PubMedCrossRef

Wang, J. J., Mitchell, P., Cumming, R. G., & Smith, W. (2003). Visual impairment and nursing home placement in older Australians: The Blue Mountains eye study. Ophthalmic Epidemiology, 10, 3–13.PubMedCrossRef

Klein, R., Klein, B. E., & Moss, S. E. (1995). Age-related eye disease and survival: The Beaver Dam eye study. Archives of Ophthalmology, 113, 333–339.PubMed

Wang, J. J., Mitchell, P., Simpson, J. M., Cumming, R. G., & Smith, W. (2001). Visual impairment, age-related cataract, and mortality. Archives of Ophthalmology, 119, 1186–1190.PubMed

Gill, T. M., & Feinstein, A. R. (1994). A critical appraisal of the quality of quality-of-life measurements. JAMA, 272, 619–626.PubMedCrossRef

10.

Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981). The sickness impact profile: Development and final revision of a health status measure. Medical Care, 19, 787–805.PubMedCrossRef

11.

Hunt, S. M., McKenna, S. P., McEwen, J., Williams, J., & Papp, E. (1981). The Nottingham Health Profile: Subjective health status and medical consultations. Social Science and Medicine, 15, 221–229.

12.

Ware, J. E. Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–483.PubMedCrossRef

13.

Mangione, C. M., Phillips, R. S., Seddon, J. M., et al. (1992). Development of the “Activities of Daily Vision Scale”: A measure of visual functional status. Medical Care, 30, 1111–1126.PubMedCrossRef

14.

Steinberg, E. P., Tielsch, J. M., Schein, O. D., et al. (1994). The VF-14: An index of functional impairment in patients with cataract. Archives of Ophthalmology, 112, 630–638.PubMed

15.

Mangione, C. M., Lee, P. P., Pitts, J., Gutierrez, P., Berry, S., & Hays, R. D. (1998). Psychometric properties of the national eye institute visual function questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Archives of Ophthalmology, 116, 1496–1504.PubMed

16.

Friedman, D. S., Tielsch, J. M., Vitale, S., Bass, E. B., Schein, O. D., & Steinberg, E. P. (2002). VF-14 item specific responses in patients undergoing first eye cataract surgery: Can the length of the VF-14 be reduced? The British Journal of Ophthalmology, 86, 885–891.PubMedCrossRef

17.

Parrish, R. K. 2nd, Gedde, S. J., Scott, I. U., Feuer, W. J., Schiffman, J. C., Mangione, C. M., & Montenegro-Piniella, A. (1997). Visual function and quality of life among patients with glaucoma. Archives of Ophthalmology, 115, 1447–1455.PubMed

18.

Linder, M., Chang, T. S., Scott, I. U., Hay, D., Chambers, K., Sibley, L. M., & Weis, E. (1999). Validity of the visual function index (VF-14) in patients with retinal disease. Archives of Ophthalmology, 117, 1611–1616.PubMed

19.

Riusala, A., Sarna, S., & Immonen, I. (2003). Visual function index (VF-14) in exudative age-related macular degeneration of long duration. American Journal of Ophthalmology, 135, 206–212.PubMedCrossRef

20.

Alonso, J., Espallargues, M., Andersen, T., Cassard, S., & Dunn, E. (1997). International applicability of the VF-14. An index of visual function in patients with cataracts. Ophthalmology, 104, 799–807.PubMed

21.

Globe, D. R., Levin, S., Chang, T. S., Mackenzie, P. J., & Azen, S. (2002). Validity of the SF-12 quality of life instrument in patients with retinal diseases. Ophthalmology, 109, 1793–1798.PubMedCrossRef

22.

Derek, M. A., Bruce, M. A., Andrew, M. D., Maxwell, A., Rajagopalan, K., Barnes, R., Harris, B., & Hileman, K. (2005). Quality-of-life improvements in cataract patients with bilateral blue light-filtering intraocular lenses: Clinical trial. Cataract and Refractive Surgery, 31, 1952–1959.CrossRef

23.

Cahill, M. T., Banks, A. D., Stinnett, S. S., & Toth, C. A. (2005). Vision- related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology, 112, 152–158.PubMedCrossRef

24.

Balkrishnan, R., Bond, J. B., Byerly, W. G., Camacho, F. T., & Anderson, R. T. (2003). Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a Medicare health maintenance organization. The American Journal of Geriatric Pharmacotherapy, 1, 75–81.PubMedCrossRef

25.

Lamoureux, E. L., Hassell, J. B., & Keeffe, J. E. (2004). The impact of diabetic retinopathy on participation in daily living. Archives of Ophthalmology, 122, 84–88.PubMedCrossRef

26.

Navarro Esteban, J. J., Gutiérrez Leiva, J. A., Valero Caracena, N., Buendia Bermejo, J., Calle Puron, M. E., & Martinez Vizcaino, V. J. (2007). Prevalence and risk factors of lens opacities in the elderly in Cuenca, Spain. European Journal of Ophthalmology, 17, 29–37.PubMed

27.

Steinberg, E. P., Tielsch, J. M., Schein, O. D., Javitt, J. C., Sharkey, P., Cassard, S. D., Legro, M. W., Diener-West, M., Bass, E. B., Damiano, A. M., et al. (1994). National study of cataract surgery outcomes. Variation in 4-month postoperative outcomes as reflected in multiple outcome measures. Ophthalmology, 101, 1131–1140.PubMed

28.

Ware, J. E., Kosinski, M., Turner-Bowker, D. M., & Gandek, B. (2002). How to score Version 2 of the SF-12 ^® health survey (with a supplement documenting Version 1). Lincoln, RI: QualityMetric Incorporated.

29.

Bailey, I. L., & Lovie, J. E. (1976). New design principles for visual acuity letter charts. American Journal of Optometry and Physiological Optics, 53, 740–745.PubMed

30.

Ferris, F. L. 3rd, Kassoff, A., Bresnick, G. H., & Bailey, I. L. (1982). New acuity charts for clinical research. American Journal of Ophthalmology, 94, 91–96.PubMed

31.

Thylefors, B., Chylack, L. T., Konyama, K., et al. (2002). A simplified cataract grading system. Ophthalmic Epidemiology, 9, 83–95.PubMedCrossRef

32.

Bayer, A., Harasymowycz, P., Henderer, J. D., Steinmann, W. G., & Spaeth, G. L. (2002). Validity of a new disk grading scale for estimating glaucomatous damage: Correlation with visual field damage. American Journal of Ophthalmology, 133, 758–763.PubMedCrossRef

33.

Bengtsson, B., Olsson, J., Heijl, A., & Rootzén, H. (1997). A new generation of algorithms for computerized threshold perimetry, SITA. Acta Ophthalmologica Scandinavica, 75, 368–375.PubMedCrossRef

34.

Bengtsson, B., & Heijl, A. (1998). Evaluation of a new perimetric threshold strategy, SITA, in patients with manifest and suspect glaucoma. Acta Ophthalmologica Scandinavica, 76, 268–272.PubMedCrossRef

35.

Bengtsson, B., & Heijl, A. (1999). Comparing significance and magnitude of glaucomatous visual field defects using SITA and full threshold strategies. Acta Ophthalmologica Scandinavica, 77, 143–146.PubMedCrossRef

36.

Artes, P. H., Iwase, A., Ohno, Y., Kitazawa, Y., & Chauhan, B. C. (2002). Properties of perimetric threshold estimates from full threshold, SITA standard, and SITA fast strategies. Investigative Ophthalmology and Visual Science, 43, 2654–2659.PubMed

37.

Sharma, A. K., Goldberg, I., Graham, S. L., & Mohsin, M. (2000). Comparison of the Humphrey Swedish interactive Thresholding algorithm (SITA) and the full threshold strategies. Journal of Glaucoma, 9, 20–27.PubMed

38.

Kristinsson, J. K. (1997). Diabetic retinopathy. Screening and prevention of blindness. Acta Ophthalmologica Scandinavica, 75(Suppl. 223), 1–76.

39.

Bird, A. C., Bressler, S., Bressler, N., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P., Klaver, C., Klein, B., Klein, R., others. (1995). An international classification and grading system for age-related macular degeneration. The International ARM Epidemiological Study Group. Survey of Ophthalmology, 39, 367–374.

40.

Cohen, J. (1977). Statistical power analysis for the behavioural sciences. New York: Academic.

41.

Rubin, G., West, S., Muñoz, B., Bandeen-Roche, K., Zeger, S., Schein, O., & Fried, L. (1997). A comprehensive assessment of visual impairment in a population of older Americans. Investigative Ophthalmology and Visual Science, 38, 557–568.PubMed

42.

Klaver, C., Wolfs, R., Vingerling, J., Hofman, A., & de Jong, P. (1998). Age-specific prevalence and causes of blindness and visual impairment in an older population. The Rotterdam Study. Archives of Ophthalmology, 116, 653–658.PubMed

43.

Buch, H., Vinding, T., La Cour, M., & Nielsen, N. V. (2001). The prevalence and causes of bilateral and unilateral blindness in an elderly urban Danish. The Copenhagen city eye study. Acta Ophthalmologica Scandinavica, 79, 441–449.PubMedCrossRef

44.

Rahmani, B., Tielsch, J., Katz, J., Gottsch, J., Quigley, H. A., Javitt, J. C., et al. (1996). The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology, 103, 1721–1726.PubMed

45.

Tsai, S. Y., Chi, L. Y., Cheng, C. Y., Hsu, W. M., Liu, J. H., & Chou, P. (2004). The impact of visual impairment and use of eye services on health-related quality of life among the elderly in Taiwan: The Shihpai Eye Study. Quality of Life Research, 13, 1415–1424.PubMedCrossRef

46.

Castells, X., Alonso, J., Ribo, C., Casado, A., Buil, J. A., Badia, M., & Castilla, M. (1999). Comparison of the results of first and second cataract eye surgery. Ophthalmology, 106, 676–682.PubMedCrossRef

47.

Parrish, R. K. 2nd (1996). Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma. Transactions of the American Ophthalmological Society, 94, 919–1028.PubMed

48.

Mackenzie, P. J., Chang, T. S., Scott, I. U., et al. (2002). Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology, 109, 720–729.PubMedCrossRef

49.

50.

Chia, E. M., Wang, J. J., Rochtchina, E., Smith, W., Cumming, R. R., & Mitchell, P. (2004). Impact of bilateral visual impairment on health-related quality of life: The Blue Mountains Eye Study. Investigative Ophthalmology and Visual Science, 45, 71–76.PubMedCrossRef

51.

Salomon, J. A., & Murria, C. J. L. (2002). Estimating health state valuations using a simple-method. In C. J. L. Murray, J. A. Salomon, C. D. Mathers, & A. D. López (Eds.), Summary measures of population health: Concepts, ethics, measurement and applications (pp. 487–500). Geneva: World Health Organization.

Titel: Visual impairment and quality of life: gender differences in the elderly in Cuenca, Spain
verfasst von: J. J. Navarro Esteban
M. Solera Martínez
P. García Navalón
O. Piñar Serrano
J. R. Cerrillo Patiño
M. E. Calle Purón
V. Martínez-Vizcaíno
Publikationsdatum: 01.02.2008
Verlag: Springer Netherlands
Erschienen in: Quality of Life Research / Ausgabe 1/2008
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-007-9280-7

Springer Professional

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu Ihrer Lizenz zu erhalten.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Springer Professional "Wirtschaft"

Weitere Artikel der Ausgabe 1/2008

Coping, meaning in life, and quality of life in congestive heart failure patients

Changes in health-related quality of life in patients of self-care vs. in-center dialysis during the first year

Measuring quality of life among cervical cancer survivors: preliminary assessment of instrumentation validity in a cross-cultural study

Health-related quality of life (HRQoL) domains most valued by urban isiXhosa-speaking people

Subjective quality of life in outpatients with schizophrenia in Hong Kong and Beijing: relationship to socio-demographic and clinical factors

Four weeks of daily assessments of anxiety, depression and activity compared to a point assessment with the Hospital Anxiety and Depression Scale